Atlas Trials

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Clinical trial NCT00326209 · COMPLETED

Trial details

NCT number
NCT00326209
Sponsor
Bausch Health Americas, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ulcerative Colitis
Start date
2005-12-22
Primary completion
2008-05-05
Enrollment
393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.